These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36625973)

  • 1. Cardiovascular reflex tests detect autonomic dysfunction in symptomatic and pre-symptomatic subjects with hereditary transthyretin amyloidosis.
    Guaraldi P; Rocchi C; Cani I; Gagliardi C; Longhi S; Baschieri F; Rinaldi R; Frezza E; D'Angelo R; Barletta G; Calandra-Buonaura G; Galiè N; Massa R; Cortelli P
    Clin Auton Res; 2023 Feb; 33(1):15-22. PubMed ID: 36625973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance neurography and diffusion tensor imaging of the sciatic nerve in hereditary transthyretin amyloidosis polyneuropathy.
    Gasparotti R; Salvalaggio A; Corbo D; Agazzi G; Cacciavillani M; Lozza A; Fenu S; De Vigili G; Tagliapietra M; Fabrizi GM; Pareyson D; Obici L; Briani C
    J Neurol; 2023 Oct; 270(10):4827-4840. PubMed ID: 37329346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Same same, but different? The neurological presentation of wildtype transthyretin (ATTRwt) amyloidosis.
    Kleefeld F; Scherret E; Knebel F; Messroghli D; Heidecker B; Wetz C; Schatka I; Barzen G; Tschöpe C; Amthauer H; Hahn K
    Amyloid; 2022 Jun; 29(2):92-101. PubMed ID: 34994254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysautonomia: A Forgotten Condition - Part 1.
    Rocha EA; Mehta N; Távora-Mehta MZP; Roncari CF; Cidrão AAL; Elias Neto J
    Arq Bras Cardiol; 2021 Apr; 116(4):814-835. PubMed ID: 33886735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world outcomes in non-endemic hereditary transthyretin amyloidosis with polyneuropathy: a 20-year German single-referral centre experience.
    Ungerer MN; Hund E; Purrucker JC; Huber L; Kimmich C; Aus dem Siepen F; Hein S; Kristen AV; Hinderhofer K; Kollmer J; Schönland S; Hegenbart U; Weiler M
    Amyloid; 2021 Jun; 28(2):91-99. PubMed ID: 33283548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered connectivity of central autonomic network: effects of dysautonomia in hereditary transthyretin amyloidosis with polyneuropathy.
    Su TJ; Lin CJ; Liu YL; Hsueh HW; Hsieh ST; Chao CC; Chiang MC
    Amyloid; 2024 Jul; ():1-9. PubMed ID: 39044725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurogenic orthostatic hypotension in early stage Parkinson's disease: New insights from the first 105 patients of the BoProPark study.
    Baschieri F; Sambati L; Guaraldi P; Barletta G; Cortelli P; Calandra-Buonaura G
    Parkinsonism Relat Disord; 2021 Dec; 93():12-18. PubMed ID: 34758441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative muscle ultrasound as a disease biomarker in hereditary transthyretin amyloidosis with polyneuropathy.
    Tan SY; Tan CY; Yahya MA; Low SC; Shahrizaila N; Goh KJ
    Neurol Sci; 2024 Jul; 45(7):3449-3459. PubMed ID: 38270729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indirect treatment comparison (ITC) of the efficacy of vutrisiran and tafamidis for hereditary transthyretin-mediated amyloidosis with polyneuropathy.
    Merkel M; Danese D; Chen C; Wang J; Wu A; Yang H; Lin H
    Expert Opin Pharmacother; 2023; 24(10):1205-1214. PubMed ID: 37219406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Widespread Cardiac and Vasomotor Autonomic Dysfunction in Non-Val30Met Hereditary Transthyretin Amyloidosis.
    Koike H; Nakamura T; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G
    Intern Med; 2018 Dec; 57(23):3365-3370. PubMed ID: 29984770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nerve ultrasonography findings as possible pitfall in differential diagnosis between hereditary transthyretin amyloidosis with polyneuropathy and chronic inflammatory demyelinating polyneuropathy.
    Leonardi L; Vanoli F; Fionda L; Loreti S; Garibaldi M; Morino S; Salvetti M; Russo D; Musumeci B; Antonini G
    Neurol Sci; 2020 Dec; 41(12):3775-3778. PubMed ID: 32936357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofilament light chain, a biomarker for polyneuropathy in systemic amyloidosis.
    Louwsma J; Brunger AF; Bijzet J; Kroesen BJ; Roeloffzen WWH; Bischof A; Kuhle J; Drost G; Lange F; Kuks JBM; Gans ROB; Hazenberg BPC; Nienhuis HLA
    Amyloid; 2021 Mar; 28(1):50-55. PubMed ID: 32883119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetization transfer ratio quantifies polyneuropathy in hereditary transthyretin amyloidosis.
    Kollmer J; Hegenbart U; Kimmich C; Hund E; Purrucker JC; Hayes JM; Lentz SI; Sam G; Jende JME; Schönland SO; Bendszus M; Heiland S; Weiler M
    Ann Clin Transl Neurol; 2020 May; 7(5):799-807. PubMed ID: 32333729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary transthyretin amyloidosis in middle-aged and elderly patients with idiopathic polyneuropathy: a nationwide prospective study.
    Fargeot G; Echaniz-Laguna A; Labeyrie C; Svahn J; Camdessanché JP; Cintas P; Chanson JB; Esselin F; Piedvache C; Verstuyft C; Genestet S; Lagrange E; Magy L; Péréon Y; Sacconi S; Signate A; Nadaj-Pakleza A; Taithe F; Viala K; Tard C; Poinsignon V; Cauquil C; Attarian S; Adams D
    Amyloid; 2024 Mar; 31(1):62-69. PubMed ID: 37855400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle quantitative MRI as a novel biomarker in hereditary transthyretin amyloidosis with polyneuropathy: a cross-sectional study.
    Vegezzi E; Cortese A; Bergsland N; Mussinelli R; Paoletti M; Solazzo F; Currò R; Ascagni L; Callegari I; Quartesan I; Lozza A; Deligianni X; Santini F; Marchioni E; Cosentino G; Alfonsi E; Tassorelli C; Bastianello S; Merlini G; Palladini G; Obici L; Pichiecchio A
    J Neurol; 2023 Jan; 270(1):328-339. PubMed ID: 36064814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen.
    Coelho T; Waddington Cruz M; Chao CC; Parman Y; Wixner J; Weiler M; Barroso FA; Dasgupta NR; Jung SW; Schneider E; Viney NJ; Dyck PJB; Ando Y; Gillmore JD; Khella S; Gertz MA; Obici L; Berk JL
    Neurol Ther; 2023 Feb; 12(1):267-287. PubMed ID: 36525140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution ultrasound of peripheral nerves in late-onset hereditary transthyretin amyloidosis with polyneuropathy: similarities and differences with CIDP.
    Leonardi L; Di Pietro G; Di Pasquale A; Vanoli F; Fionda L; Garibaldi M; Galosi E; Alfieri G; Lauletta A; Morino S; Salvetti M; Truini A; Antonini G
    Neurol Sci; 2022 May; 43(5):3387-3394. PubMed ID: 34802089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axonal excitability as an early biomarker of nerve involvement in hereditary transthyretin amyloidosis.
    Carroll AS; Park SB; Lin CSY; Taylor MS; Kwok F; Simon NG; Reilly MM; Kiernan MC; Vucic S
    Clin Neurophysiol; 2024 Mar; 159():81-95. PubMed ID: 38377648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nerve ultrasound in hereditary transthyretin amyloidosis: red flags and possible progression biomarkers.
    Salvalaggio A; Coraci D; Cacciavillani M; Obici L; Mazzeo A; Luigetti M; Pastorelli F; Grandis M; Cavallaro T; Bisogni G; Lozza A; Gemelli C; Gentile L; Ermani M; Fabrizi GM; Plasmati R; Campagnolo M; Castellani F; Gasparotti R; Martinoli C; Padua L; Briani C
    J Neurol; 2021 Jan; 268(1):189-198. PubMed ID: 32749600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiomyopathy correlates to nerve damage in p.A117S late-onset transthyretin amyloid polyneuropathy.
    Lin YH; Hsueh HW; Su MY; Cheng MF; Chiang MC; Juang JJ; Kao YH; Chang KC; Feng FP; Hsieh ST; Chao CC
    Ann Clin Transl Neurol; 2022 Sep; 9(9):1359-1369. PubMed ID: 35945697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.